Stockholders’ Equity |
3 Months Ended |
|---|---|
Sep. 30, 2026 | |
| Equity [Abstract] | |
| Stockholders’ Equity | Note 12 – Stockholders’ Equity
As of September 30, 2026 and June 30, 2026, the Company had 110,000,000 shares of authorized capital, par value $0.001, of which 100,000,000 shares are designated as common stock, and 10,000,000 shares are designated as preferred stock.
Equity Transactions
During the three months ended September 30, 2026, 17,279 shares of common stock were issued upon the exercise of stock options at $3.74 per share, including 1,505 shares for options exercised on June 30, 2026.
During the three months ended September 30, 2026, 679 shares of common stock were retired.
During the three months ended September 30, 2025, 44,357 stock options were exercised at $3.74 per share of common stock.
As of September 30, 2026 and June 30, 2026 the Company had 12,813,821 and 12,797,221 shares of common stock outstanding, respectively, and no shares of preferred stock issued and outstanding.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The entire disclosure for equity. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|